Cite
HARVARD Citation
Reiser, M. et al. (2017). Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long‐term data of the SIGNS study. European journal of haematology. pp. 169-177. [Online].